FDA Approves First-Ever Blood Test to Diagnose Alzheimer’s

Watch FDA Approves First-Ever Blood Test to Diagnose Alzheimer’s - Rizzle on Dailymotion

Transcript

00:00FDA approves first ever blood test to diagnose Alzheimer's.

00:05The FDA approved the LumiPulse test, a groundbreaking diagnostic tool for early stage Alzheimer's

00:10diagnosis, enhancing treatment effectiveness for affected patients.

00:17The Alzheimer's blood test is capable of determining the presence of amyloid plaques

00:21in the brains of adult patients who are aged 55 or older.

00:26The new Alzheimer's blood test is able to measure both the tau and amyloid proteins

00:30present in human plasma.

00:35The FDA found LumiPulse test 92% effective, matching spinal tap and PET scan results.

00:45Over 97% of those testing negative with the Alzheimer's blood test also showed negative

00:50results in spinal tap or PET scans.

00:56Priced between $500 to $1,000, it provides a lifeline, avoiding spinal tap expenses and radiation

01:03exposure from brain imaging, offering a convenient alternative for countless individuals.

01:11Alzheimer's disease leads to a progressive decline in cognitive abilities.

01:16Early diagnosis not only enhances treatment effectiveness, but also enables patients

01:20to manage their lives while mentally capable.

01:24The LumiPulse Alzheimer's blood test, FDA approved, is the first of its kind.

01:31Other promising tests, like the AD detect test, await approval.

01:35Although no blood test alone can diagnose Alzheimer's, these tests are increasingly used as initial,

01:41non-invasive detection methods.

01:46Howard Fillet emphasizes a transformative era in Alzheimer's diagnosis, with blood-based biomarkers

01:52enabling precision medicine.

01:53Howard Fillet estrogen

02:05pelo the LumiPulse Alzheimer's, FDA cleanse implant

02:05jamin ALECный SOSHI

02:06ичеztoriums